Avoid and Resist Strategies for Weight Management
Trial Summary
What is the purpose of this trial?
This trial tests two methods to help people with overweight or obesity lose weight and eat healthier. One method changes the home food environment to make healthier choices easier (AVOID), and the other improves self-control over food choices through training (RESIST).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have conditions like unstable coronary artery disease or uncontrolled insulin-dependent diabetes, you may not be eligible to participate.
What data supports the effectiveness of the treatment involving home food environment and grocery delivery, online grocery shopping and delivery, and cognitive control training for weight management?
Is the Avoid and Resist Strategies for Weight Management treatment safe for humans?
How does the Avoid and Resist Strategies for Weight Management treatment differ from other weight management treatments?
This treatment is unique because it focuses on cognitive strategies like episodic future thinking (EFT) and response inhibition training to help individuals make healthier food choices and reduce calorie intake, rather than relying on traditional methods like diet or exercise alone. These cognitive approaches aim to change how people think about food and their future, which can lead to more sustainable weight management.57101112
Research Team
Sarah-Jeanne Salvy, PhD
Principal Investigator
Cedars-Sinai Medical Center
Eligibility Criteria
This trial is for adults and children over 14 with obesity, having a BMI between 25-40. Participants must be able to read, write, and speak English with good vision. Children under 18 need parent consent. It's aimed at those willing to complete various assessments.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are enrolled in a 12-month weight-management program and randomized to one of four study arms: WW only, WW + AVOID, WW + RESIST, or WW + AVOID + RESIST.
Follow-up
Participants are monitored for changes in health, diet, and exercise, and complete participant experience interviews.
Treatment Details
Interventions
- Home food environment and grocery delivery (Behavioral Intervention)
- Inhibitory control training (Behavioral Intervention)
- WW (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cedars-Sinai Medical Center
Lead Sponsor
David E. Cohen
Cedars-Sinai Medical Center
Chief Medical Officer
MD and PhD in Physiology and Biophysics from Harvard University
Peter L. Slavin
Cedars-Sinai Medical Center
Chief Executive Officer
MD from Harvard Medical School, MBA from Harvard Business School
Northeastern University
Collaborator
Jared Auclair
Northeastern University
Chief Executive Officer
PhD in Biomedical Science from the University of Massachusetts Medical School
Anantdeep Kaur
Northeastern University
Chief Medical Officer since 2023
Master’s and Doctorate in Biotechnology from the University of Technology Sydney
WW International Inc
Industry Sponsor
Weight Watchers International
Industry Sponsor
The University of Tennessee, Knoxville
Collaborator
Randy Boyd
The University of Tennessee, Knoxville
Chief Executive Officer since 2019
Bachelor's degree from the University of Tennessee, Knoxville
Dr. Ogram
The University of Tennessee, Knoxville
Chief Medical Officer since 2018
PhD in Microbiology with a concentration in Molecular Virology from the University of Tennessee, Knoxville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Dr. Griffin P. Rodgers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chief Executive Officer since 2007
MD, M.A.C.P.
Dr. Griffin P. Rodgers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chief Medical Officer since 2007
MD, M.A.C.P.
University of California, Riverside
Collaborator